Efficacy and safety of darbepoetin alfa injection replacing epoetin alfa injection for the treatment of renal anemia in Chinese hemodialysis patients: A randomized, open‐label, parallel‐group, noninferiority phase III trial

BACKGROUND: This study was to explore the clinical efficacy and safety of darbepoetin alfa injection replacing epoetin alfa injection (recombinant human erythropoietin injection, rHuEPO) for the treatment of anemia associated with chronic kidney failure in Chinese patients undergoing hemodialysis. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Bicheng, Chen, Nan, Zhao, Jinghong, Yin, Aiping, Wu, Xiongfei, Xing, Changying, Jiang, Gengru, Fu, Junzhou, Wang, Mei, Wang, Rong, Niu, Jianying, Fu, Ping, Ni, Zhaohui, Hou, Fanfan, Zhao, Jiuyang, Chen, Jing, Chen, Yuqing, Shi, Wei, Chen, Jianghua, Li, Wenge, Xu, Gang, Zhong, Ling, Liu, Wenhu, Ding, Guohua, Kondo, Yuichiro, Yue, Changhe, Mei, Changlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215713/
https://www.ncbi.nlm.nih.gov/pubmed/35774427
http://dx.doi.org/10.1002/cdt3.23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215713/
https://www.ncbi.nlm.nih.gov/pubmed/35774427
http://dx.doi.org/10.1002/cdt3.23

Ejemplares similares